Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
The Open Respiratory Medicine Journal
|
May 20, 2009
New pharmacologic perspectives in pneumology: beclomethasone-formoterol extrafine
Pierluigi Paggiaro
American Journal of Respiratory and Critical Care Medicine
|
June 10, 2004
Does early treatment of exacerbation improve outcome in chronic obstructive pulmonary disease?
Pierluigi Paggiaro
Current Opinion in Pulmonary Medicine
|
December 12, 2002
Inhaled corticosteroids and leukotriene modifiers in the acute treatment of asthma exacerbations
Antonio Foresi, Pierluigi Paggiaro
Annali Dell'Istituto Superiore Di Sanita
|
April 22, 2004
[Clinical aspects of chronic obstructive pulmonary disease]
Pierluigi Paggiaro, Barbara Vagaggini
Therapeutic Advances in Chronic Disease
|
December 20, 2012
Montelukast in asthma: a review of its efficacy and place in therapy
Pierluigi Paggiaro, Elena Bacci
Expert Review of Respiratory Medicine
|
January 31, 2012
The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives
Nicolino Ambrosino, Pierluigi Paggiaro
The Journal of Allergy and Clinical Immunology. in Practice
|
July 10, 2016
Reply
Pierluigi Paggiaro, Manuela Latorre
Pulmonology
|
February 9, 2020
Is adherence to treatment influenced by the ability to use inhaled devices in patients with COPD correctly?
Manuela Latorre, Giulia Parri, Pierluigi Paggiaro
Expert Review of Respiratory Medicine
|
May 19, 2010
Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma
Pierluigi Paggiaro, Gabriele Nicolini, Alberto Papi
Respiration; International Review of Thoracic Diseases
|
September 4, 2015
Assessing exercise performance during exacerbations of chronic obstructive pulmonary disease: work smarter, not harder!
Christian Osadnik, Barbara Vagaggini, Pierluigi Paggiaro
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
The Open Respiratory Medicine Journal
|
May 20, 2009
New pharmacologic perspectives in pneumology: beclomethasone-formoterol extrafine
Pierluigi Paggiaro
American Journal of Respiratory and Critical Care Medicine
|
June 10, 2004
Does early treatment of exacerbation improve outcome in chronic obstructive pulmonary disease?
Pierluigi Paggiaro
Current Opinion in Pulmonary Medicine
|
December 12, 2002
Inhaled corticosteroids and leukotriene modifiers in the acute treatment of asthma exacerbations
Antonio Foresi, Pierluigi Paggiaro
Annali Dell'Istituto Superiore Di Sanita
|
April 22, 2004
[Clinical aspects of chronic obstructive pulmonary disease]
Pierluigi Paggiaro, Barbara Vagaggini
Therapeutic Advances in Chronic Disease
|
December 20, 2012
Montelukast in asthma: a review of its efficacy and place in therapy
Pierluigi Paggiaro, Elena Bacci
Expert Review of Respiratory Medicine
|
January 31, 2012
The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives
Nicolino Ambrosino, Pierluigi Paggiaro
The Journal of Allergy and Clinical Immunology. in Practice
|
July 10, 2016
Reply
Pierluigi Paggiaro, Manuela Latorre
Pulmonology
|
February 9, 2020
Is adherence to treatment influenced by the ability to use inhaled devices in patients with COPD correctly?
Manuela Latorre, Giulia Parri, Pierluigi Paggiaro
Expert Review of Respiratory Medicine
|
May 19, 2010
Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma
Pierluigi Paggiaro, Gabriele Nicolini, Alberto Papi
Respiration; International Review of Thoracic Diseases
|
September 4, 2015
Assessing exercise performance during exacerbations of chronic obstructive pulmonary disease: work smarter, not harder!
Christian Osadnik, Barbara Vagaggini, Pierluigi Paggiaro
Page
of 16